Subacute Central Nervous System Degeneration in a Child: An Unusual Manifestation of Ifosfamide Intoxication

Abstract

A 5-year-old child with desmoplastic small round-cell tumor was treated with a protocol of very-high-dose, short-term chemotherapy, containing HD-CAV (cyclophosphamide, doxorubicin, vincristine, and mesna), ifosfamide, and etoposide. Two days after the initiation of ifosfamide, he exhibited new-onset lethal encephalopathy manifested by subacutely progressive cerebellar and then temporal and frontocortical degeneration leading to a vegetative state and eventually to death. A full work-up, including brain biopsy, was negative, excluding infections and metabolic or vascular causes. Ifosfamide is known to be capable of causing acute encephalopathy that can be severe but is generally reversible. This child showed a very atypical progressive, lethal course of ifosfamide toxicity. The possibility of this complication should be considered when high-dose ifosfamide treatment is planned for children. (J Child Neurol 2000;15:481-483).

Get full access to this article

View all access options for this article.

References

Pratt CB , Green AA , Horowitz ME , et al: Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/ mesna. J Clin Oncol 1986;4:1253-1261.

Antman KH , Elias A. , Ryan L. : Ifosfamide and mesna: Response and toxicity at standard and high dose schedules . Semin Oncol 1990;1:68-73.

Kupfer A. , Aeschlimann C. , Cedny T. : Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy . Eur J Clin Pharmacol 1996; 50:249-252.

Kushner BH , Meyers PA , Gerald WL , et al: Very high-dose, short-term chemotherapy for poor risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma in children and young adults. J Clin Oncol 1995;13:2796-2804.

Hurwitz RL , Mahoney DH , Armstrong DL , Browder TM : Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 1988;16:216-219.

Meanwell CA , Blake AE , Latif TN , et al: Encephalopathy associated with ifosphamide/mesna therapy. Lancet 1985;1:406-407.

7. Bruggers CS , Friedman HS , Tien R. , Delong R. Cerebral atrophy in an infant following treatment with ifosfamide . Med Pediatr Oncol 1994; 23:380-383.

Scheithauer W. , Ludwig H. , Maida E. : Acute encephalopathy with continuous vincristine sulfate combination therapy: Case report. Invest New Drugs 1985;3:315-318.

Mason WP , Graus F. , Lang B. , et al: Small cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300.

10.

Vickers SM , Niederhuber JE : Hodgkin's disease associated with neurologic paraneoplastic syndrome . South Med J 1997;90:839-844.

11.

Posner JB : Paraneoplastic syndromes. Curr Opin Neurol 1997;10:471-476.

12.

Kupfer A. , Aeschlimann C. , Wedmuth B. , Cedny T. : Prophylaxis and reversal of ifosfamide encephalopathy with methylene blue . Lancet 1994;343:763-764.

13.

Julian GB , Tullen E. , Maton B. : Methylene blue for ifosfamide-associated encephalopathy. Lancet 1995;33:1239-1240.